Biomagnetics Announces Webinar by Los Alamos
National Security, LLC
August 19, 2010 09:33 AM Eastern Daylight Time
SAN FRANCISCO--(EON: Enhanced Online News)--Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP)
a developer of revolutionary diagnostic systems and other innovative technologies, today announced that Dr.
Harshini Mukundan, Scientist at Los Alamos National Laboratories (“LANL”) will be presenting a technical
“webinar,” or web-based seminar, to scientific attendees on the Integrated Optical Biosensor Development (IOBS)
technology developed at LANL. Those affiliated with BMGP are welcome to attend.
Biomagnetics has entered into a Patent License Agreement and Collaborative Research and Development
Agreement (CRADA) with Los Alamos National Security, LLC. Under the agreements, Biomagnetics will have
access to the IBOS technology. BMGP’s initial focus will be on tuberculosis, cholera and malaria diagnosis.
Clayton Hardman, CEO of Biomagnetics, stated that he and Dr. Mukundan recently completed a trip to India that
included meeting with the Director General of Health Services, R.K. Srivastava, the Tuberculosis Research Centre
and the National Institute of Malaria Research. The purpose of these meetings was to establish the ground rules for
collaboration leading to successful conclusion of clinical trials.
The webinar will explore the genesis of the IOBS Unit as well as a simplified technical review of the system versus
current diagnostic methodology.
WHEN: Friday, August 27, 2010
TIME and LINK: To follow
About Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company and an acquirer
other innovative technologies. The Company’s revolutionary diagnostic systems, which are based on advanced
waveguide and magnetics technologies, can test for all viral or bacterial diseases. The Company's technology allows
laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP